1-2 of 2
A. Binckebanck
Close
Sort by
Journal Articles

Imatinib (IM) and Interferon-Alpha (IFN-a) Maintenance Therapy Is Associated with Long-Term DFS in a Subset of Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Heike Pfeifer, MD, Sylvia Wystub, PhD, A. Binckebanck, Barbara Wassmann, Andreas Käbisch, Michael Lübbert, MD, Lothar Leimer, MD, Aristoteles Giagounidis, MD, Winfried Gassmann, MD, PhD, Patrick Brueck, MD, Hubert Serve, Prof. Dr. med., Dieter Hoelzer, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2012) 120 (21): 1503.
https://doi.org/10.1182/blood.V120.21.1503.1503
Published: 2012
Journal Articles

Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Heike Pfeifer, MD, Nicola Goekbuget, MD, Christian Völp, MD, Andreas Hüttmann, MD, Michael Lübbert, MD, Reingard Stuhlmann, MD, Julanta Dengler, MD, Karl-Anton Kreuzer, MD, Joachim Beck, MD, Matthias Stelljes, MD, Mathias Schmid, MD, B. Wassmann, MD, Lothar Leimer, MD, Karsten Spiekermann, MD, Theis H Terwey, MD, K. Schäfer-Eckart, MD, D. Ditz, MD, H. Lindemann, MD, A. Morgner, MD, Markus Schaich, MD, Thomas Burmeister, MD, A. Binckebanck, Dieter Hoelzer, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2010) 116 (21): 173.
https://doi.org/10.1182/blood.V116.21.173.173
Published: 2010